Wednesday, August 15, 2018
Home Clinical Trial Updates

Clinical Trial Updates

Results from a phase III, randomized, double-blind, international clinical study (AUGMENT trial | NCT01938001). lenalidomide (REVLIMID®; Celgene) plus rituximab (MabThera®; Roche / Rituxan®; Genentech) achieved a highly statistically significant improvement in the primary endpoint of progression-free survival (PFS), compared...
Friends of Cancer Research, an organization focusing on the collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed lifesaving treatments to patients, has released the results of a unique pilot project,...
In a randomized phase III trial patients with surgically removed pancreatic cancer who received modified FOLFIRINOX (mFOLFIRINOX), a chemotherapy regimen containing four different medicines including oxaliplatin, leucovorin, and irinotecan administered intravenously (IV) at day 1, followed by 5-fluorouracil via...
A randomized, phase III trial, called PREOPANC-1, funded in part by the Dutch Cancer Society KWF/Koningin Wilhelmina Fonds, found that people who received chemotherapy with radiation, also known as chemoradiotherapy, before pancreatic cancer surgery had better disease-free survival than...
A pilot study has shown large variations between European countries in patient survival after surgery for esophageal and gastric cancers. The data presented by Dutch researchers at the 2013 European Cancer Congress (ECC2013) shows that the reasons for these...
Results from a clinical trial of a new treatment for glioblastoma (GBM) suggest that researchers may have found a new approach to treating this most aggressive of brain tumors, as well as a potential new biological marker than can...
While much progress has been made in the "war" against cancer, a new report, presented at the 2013 European Cancer Congress (ECCO 2013) being held in Amsterdam, The Netherlands, September 27 - October 1, 2013, shows that not everycancerpatient...
Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remained, so far, unknown.Now, new research shows that aspirin improves outcome in patients whose tumour...
A new report, presented at the 2013 European Cancer Congress (ECC2013) shows that, for the first time, researchers have been able to estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that...
New study results presented at the 2013 European Cancer Congress (ECC2013), vein held in Amsterdam, The Netherlands, seem to suggest that women with ovarian cancer that has recurred after chemotherapy, have survived for longer after treatment with a biological...

Related articles